HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Calcipotriol for erythema annulare centrifugum.

Abstract
: Erythema annulare centrifugum (EAC) is an uncommon inflammatory skin disease of unknown aetiology. No therapy is currently available. We describe a 73-year-old woman with a 3-year history of EAC that was resistant to topical and systemic glucocorticoids, antifungals, and psoralen plus ultraviolet A treatment. After 3 months of treatment with topical calcipotriol the lesions cleared completely and did not recur during a 6-month follow-up period. Vitamin D analogues may be of value in the therapy of EAC.
AuthorsR Gniadecki
JournalThe British journal of dermatology (Br J Dermatol) Vol. 146 Issue 2 Pg. 317-9 (Feb 2002) ISSN: 0007-0963 [Print] England
PMID11903248 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Dermatologic Agents
  • calcipotriene
  • Calcitriol
Topics
  • Aged
  • Calcitriol (analogs & derivatives, therapeutic use)
  • Dermatologic Agents (therapeutic use)
  • Erythema (drug therapy, pathology)
  • Female
  • Follow-Up Studies
  • Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: